Data Quality vs Quantity issue with ML and AI applications with Arvind Balasundaram

As AI and Machine Learning gain momentum, the spotlight on data quality versus quantity intensifies.
In this week’s CDO Insight series we have with us Arvind Balasundaram who with over twenty years of experience, is a prominent figure in the realm of commercial insights and analytics. His extensive career has seen him specialize in global customer insights, strategic analytics, and market research. Renowned for his adept use of data and analytics, he fuels actionable insights and strategic choices within the pharmaceutical sector. For more than five years, Arvind has been at the helm of Regeneron Pharmaceuticals' Commercial Insights & Analytics division, playing a pivotal role in the company's expansion and success. Prior to joining Regeneron, he held distinguished positions, including Head of Global Customer Insights at Sanofi and Senior Director at Johnson & Johnson. As
Subscribe or log in to Continue Reading

Uncompromising innovation. Timeless influence. Your support powers the future of independent tech journalism.

Already have an account? Sign In.

📣 Want to advertise in AIM Media House? Book here >

Picture of 理想
理想
AIM is the world's leading media and analyst firm dedicated to advancements and innovations in Artificial Intelligence. Reach out to us at info@aimmediahouse.com
25 July 2025 | 583 Park Avenue, New York
The Biggest Exclusive Gathering of CDOs & AI Leaders In United States

Subscribe to our Newsletter: AIM Research’s most stimulating intellectual contributions on matters molding the future of AI and Data.